ir para o conteúdo principal
Logo Default
Portugal in Numbers

Clinical Research as a strategic priority for the country

In the last years, there has been a significant growth in number and sample size of clinical trials in Portugal covering different therapeutic areas and Clinical Research Centers

Img 02
27th place
The Global Competitiveness Report (2019)
13th place
Euro Health Consumer Index (2018)
4th place
Global Observatory on Health R&D (2022)
Biggest performance increase compared to 2018 within the group of "Strong Innovators"
European Innovation Scoreboard
1.5 normalized citation impact
Produção Científica Portuguesa: Indicadores Bibliométricos 2016-2020 – DGEEC (February 2022)
Submitted and Approved Clinical Trials
Source: INFARMED, I.P.
Clinical Trials submitted by phase
Source: INFARMED, I.P.
Clinical Trials submitted by therapeutic area
* Endocrine System (H), Genital-Urinary System and Sex Hormones (G), Dermatological (D), Various (V) Antiparasiticides and Insecticides and Repellents (P) | Source: INFARMED, I.P.
Evaluation and authorization of clinical trials involving medical devices
Source: Relatórios Atividade INFARMED
Submitted Clinical Trials by Sponsor Type
Source: INFARMED, I.P.
Average approval decision time (in calendar days)
Source: INFARMED, I.P.
Average time to issue ethical opinion for conducting a clinical trial (working days)
Source: CEIC
Ethical opinion for conducting a clinical trial
Source: CEIC